News

Werman’s World

Marco Werman, host of the international news program “The World” explains his role as the first journalist in residence at UC San Diego and shares his thoughts about life on campus thus far. Click here […]

No Picture
News

Neurocrine Biosciences Presents INGREZZA® (valbenazine) Capsules Data on Tardive Dyskinesia Improvement Regardless of Baseline Antipsychotic Use at 2023 Psych Congress Elevate

SAN DIEGO, June 2, 2023 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today presented findings from a meta-analysis of three long-term studies evaluating INGREZZA® (valbenazine) capsules that demonstrated substantial and sustained improvements in tardive dyskinesia […]

No Picture
News

Biological Dynamics to Highlight ExoLuminate Study for Early Detection of Pancreatic Cancer in High-Risk Populations at ASCO Annual Meeting

SAN DIEGO–(BUSINESS WIRE)–Biological Dynamics presents clinical study further validating its assay for early pancreatic cancer detection in higher-risk patients at ASCO. Click here to view original post

No Picture
News

Invivoscribe Partners with Complete Genomics to Develop and Commercialize Biomarker Tests for Oncology and Cancer Research

SAN DIEGO and SAN JOSE, Calif., June 2, 2023 /PRNewswire/ — Invivoscribe and Complete Genomics announced today that they had entered a partnership to develop and commercialize biomarker tests on Complete Genomics’ NGS platforms. The […]

No Picture
News

Debut Raises $34M in Series B Funding Led by L’Oréal To Create the Next Generation of High-Performing Active Ingredients

The partnership with BOLD, L’Oréal’s venture capital fund, will enable Debut to bring novel bioactive cosmetic ingredients and products to consumers worldwide SAN DIEGO, June 1, 2023 /PRNewswire/ –?Debut, a vertically integrated synthetic biology company […]

No Picture
News

Navigate BioPharma Services, Inc. launches new multiplex digital PCR assay for comprehensive quantification of up to 5 different CAR-T transgenes

CARLSBAD, Calif., June 1, 2023 /PRNewswire/ — During this year’s AAPS National biotechnology conference, Navigate BioPharma Services, Inc., a Novartis subsidiary and a leading provider of innovative biomarker solutions for drug development, announced the launch […]

No Picture
News

Bayer buys license to Cedilla preclinical cancer program; MEI Pharma says no to unsolicited offer

Bayer has acquired exclusive rights to Cedilla Therapeutics’ preclinical cancer drug candidates for an undisclosed amount. Bayer announced Thursday morning that it is acquiring the license for Cedilla’s preclinical Cyclin E1/CDK2 complex inhibitors. Cyclin E1 […]

No Picture
News

Equillium to Present at the Jefferies Global Healthcare & LD Micro Invitational Conferences

LA JOLLA, Calif.–(BUSINESS WIRE)—- $EQ–Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced that it will present […]